Data / Research funding / Cocaine
Cocaine: 427 NIH awards ($581.8M) to 160 organizations
427 NIH awards ($581.8M) in the NIH spending category Cocaine, to 160 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
427 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $43,417,361 | March 1, 2025 | February 28, 2032 | TRIVEDI, MADHUKAR H. | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,516,969 | June 1, 2022 | March 31, 2027 | ZENG, HONGKUI | reporter.nih.gov |
| Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,564,620 | September 1, 2021 | June 30, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $8,683,509 | September 30, 2022 | July 31, 2025 | TOLL, LAWRENCE R | reporter.nih.gov |
| Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $8,242,506 | August 15, 2020 | April 30, 2026 | ZHAN, CHANG-GUO | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| Cohort Studies of HIV/AIDS and Substance Use in Miami | NIH | National Institute on Drug Abuse | 2025 | $7,372,834 | September 30, 2025 | June 30, 2030 | BAUM, MARIANNA K | reporter.nih.gov |
| Development of sigma receptor/DAT dual-targeting compounds to treat stimulant use disorder | NIH | National Institute on Drug Abuse | 2023 to 2024 | $6,903,733 | August 15, 2023 | July 31, 2026 | REICH, JEFFREY | reporter.nih.gov |
| PDE7 Inhibitor for the Treatment of Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,689,019 | April 15, 2023 | March 31, 2027 | GAITANARIS, GEORGE | reporter.nih.gov |
| Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $6,266,450 | June 15, 2022 | March 31, 2027 | CHENG, CHRISTINE | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| TMP-301, A Negative Allosteric Modulator of type 5 metabotropic glutamate receptors (mGluR5), for Treatment of Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2022 to 2023 | $5,310,920 | September 1, 2022 | August 31, 2025 | MEYERS, CHARLES DANIEL | reporter.nih.gov |
| Development of TNX-1300 (Double Mutant Cocaine Esterase) for the Treatment of Life-Threatening Cocaine Intoxication | NIH | National Institute on Drug Abuse | 2022 to 2025 | $5,181,674 | August 1, 2022 | November 30, 2025 | SULLIVAN, GREGORY M | reporter.nih.gov |
| Discovery of Addiction-Related Genes with Advanced Mouse Resources | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,405,786 | April 1, 2015 | May 31, 2027 | CHESLER, ELISSA J | reporter.nih.gov |
| Single nuclei transcriptome profiling in addiction circuitry of the HIV+ brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,310,228 | April 1, 2021 | February 28, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Identification of Genetic Variants that Contribute to Compulsive Cocaine Intakein Rats | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,976,898 | April 1, 2017 | June 30, 2027 | GEORGE, OLIVIER | reporter.nih.gov |
| Early Life Stress, Chronic Drug Use and Neuroplasticity in Nonhuman Primate Models of Cocaine Abuse: Relevance to Treatment Strategies | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,974,079 | April 1, 2021 | January 31, 2027 | SANCHEZ, MAR M | reporter.nih.gov |
| The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,680,536 | April 1, 2020 | May 31, 2029 | HUYBRECHTS, KRISTA F | reporter.nih.gov |
| Understanding neuronal subtype-specific function of NAc in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,661,419 | April 1, 2021 | February 28, 2026 | ZHANG, YI | reporter.nih.gov |
| Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C UCB J PET Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,657,020 | July 1, 2021 | April 30, 2027 | ANGARITA, GUSTAVO ADOLFO | reporter.nih.gov |
| Small molecule modulators of ΔFosB | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,586,553 | July 1, 2016 | March 31, 2027 | RUDENKO, GABRIELLE | reporter.nih.gov |
| PTPRD Phosphatase inhibitors for stimulant use disorders | NIH | National Institute on Drug Abuse | 2022 to 2024 | $3,540,141 | July 1, 2022 | June 30, 2025 | UHL, GEORGE RICHARD | reporter.nih.gov |
| Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,446,099 | July 1, 2020 | April 30, 2026 | AUGELLI-SZAFRAN, CORINNE ELIZABETH | reporter.nih.gov |
| Epigenetic mechanisms of sustained transcription across cocaine abstinence | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,351,544 | July 1, 2021 | May 31, 2026 | HELLER, ELIZABETH A | reporter.nih.gov |
| Drug development of clavulanic acid, a GLT-1 activator: proof of concept for cocaine use disorder | NIH | National Institute on Drug Abuse | 2022 to 2023 | $3,340,215 | May 15, 2020 | December 31, 2024 | MORRISON, MARY F. | reporter.nih.gov |
| Genetics of novelty seeking and propensity for drug abuse in outbred rats | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,193,903 | September 1, 2023 | June 30, 2028 | AKIL, HUDA | reporter.nih.gov |
| Cocaine use, viral suppression and precursors of stroke in HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,185,105 | June 1, 2020 | April 30, 2026 | RILEY, ELISE D. | reporter.nih.gov |
| Contingency management plus deep transcranial magnetic stimulation for the treatment of cocaine use disorder | NIH | National Institute on Drug Abuse | 2025 | $3,119,619 | September 15, 2025 | June 30, 2029 | SCHMITZ, JOY MARIE | reporter.nih.gov |
| PET Imaging of neurochemical transmission in cocaine use disorders | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,096,100 | September 30, 2009 | June 30, 2027 | NARENDRAN, RAJESH | reporter.nih.gov |
| Mechanisms Mediating Cocaine Abuse in Socially Housed Female and Male Monkeys | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,072,958 | September 1, 2001 | May 31, 2029 | NADER, MICHAEL A | reporter.nih.gov |
| cART, neuroHIV, cocaine abuse and the mPFC neuron/astrocyte dysfunction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,070,264 | September 15, 2022 | August 31, 2027 | HU, XIU-TI | reporter.nih.gov |
| Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,027,776 | September 30, 2022 | July 31, 2027 | ALEXANDER, KAREN | reporter.nih.gov |
| Atherosclerosis in cocaine addiction: imaging risk with PET/MR | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,015,410 | June 1, 2022 | March 31, 2027 | ALIA-KLEIN, NELLY | reporter.nih.gov |
| AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,004,104 | March 15, 2021 | February 28, 2027 | CISNEROS, IRMA | reporter.nih.gov |
| Molecular Studies of Cocaine Action in Brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,971,622 | August 1, 1991 | January 31, 2026 | NESTLER, ERIC J. | reporter.nih.gov |
| Role of GRIN2 in ART and SUD associated neurological deficits. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,965,829 | September 15, 2022 | August 31, 2027 | DASH, CHANDRAVANU | reporter.nih.gov |
| The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,923,597 | July 1, 2023 | June 30, 2025 | NWAOKOBIA, CHARLES CHIEDU | reporter.nih.gov |
| D1 and D2 Dopaminoceptive Ensembles in Limbic Brain Regions in Drug Addiction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,909,999 | September 1, 2000 | April 30, 2030 | NESTLER, ERIC J. | reporter.nih.gov |
| Reelin Signaling and Function in Cocaine Response | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,847,900 | July 1, 2021 | April 30, 2027 | DAY, JEREMY J | reporter.nih.gov |
| An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,821,784 | July 15, 2022 | April 30, 2027 | LACONTE, STEPHEN M | reporter.nih.gov |
| In Vivo Characterization of 5-HT7 Modulators in Rat Models of Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,820,000 | June 1, 2022 | May 31, 2026 | PIPPIN, DOUGLAS ANTHONY | reporter.nih.gov |
| Drug abuse and HIV-associated pulmonary vascular injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,784,947 | February 1, 2021 | December 31, 2025 | DHILLON, NAVNEET KAUR | reporter.nih.gov |
| Gene Network Identification and Integration (GNetii) Approach to Understanding the Biology Underlying HIV and Drug Abuse. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,762,265 | August 1, 2020 | May 31, 2026 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| Sex differences in the neural correlates underlying impairments in response inhibition and salience attribution in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,749,037 | April 1, 2020 | February 28, 2025 | GOLDSTEIN, RITA Z | reporter.nih.gov |
| Altered Midbrain GABAergic Circuitry Drives Greater Cocaine Self-administration | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,670,057 | May 15, 2021 | February 28, 2026 | DANI, JOHN A. | reporter.nih.gov |
| Epigenetic mechanisms in the medial habenula governing drug-seeking behavior | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,638,720 | July 15, 2020 | April 30, 2026 | WOOD, MARCELO ANDRES | reporter.nih.gov |
| Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitry | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,612,514 | September 15, 2014 | June 30, 2027 | LOBO, MARY KAY | reporter.nih.gov |
| Role of Gadd45b in Cocaine-driven Epigenetic and Behavioral Dynamics | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,581,972 | May 1, 2022 | March 31, 2027 | DAY, JEREMY J | reporter.nih.gov |
| Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,568,075 | May 1, 2020 | January 31, 2026 | MOELLER, FREDERICK GERARD | reporter.nih.gov |
| A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,557,655 | May 1, 2020 | January 31, 2026 | KAMPMAN, KYLE MATTHEW | reporter.nih.gov |
| Kappa Opioid Receptors and Phospho-Dopamine Transporters Drive Cocaine Reward | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,532,199 | September 15, 2022 | June 30, 2027 | RAMAMOORTHY, SAMMANDA | reporter.nih.gov |
| Genetics of Cocaine Sensitivity in Drosophila | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,469,830 | September 15, 2017 | April 30, 2027 | MACKAY, TRUDY F. | reporter.nih.gov |
| Parvalbumin interneurons regulate nucleus accumbens synapses and behavior | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,435,138 | September 1, 2016 | May 31, 2026 | GRUETER, BRAD ALAN | reporter.nih.gov |
| MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE. PERIOD OF PERFORMANCE: 7/10/2019-7/9/2024. N01DA-19-8949 | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,430,107 | July 10, 2019 | July 9, 2024 | SHELTON, KEITH | reporter.nih.gov |
| Mechanisms of dopaminergic dysfunction in substance use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,425,095 | September 30, 2021 | July 31, 2026 | CALIPARI, ERIN | reporter.nih.gov |
| Neighborhood conditions, neural circuits, and substance use behaviors across the early life course. | NIH | National Institute on Drug Abuse | 2025 | $2,314,254 | September 30, 2025 | June 30, 2029 | BARR, PETER BRENDAN | reporter.nih.gov |
| Impact of prescription stimulants on the drug overdose epidemic | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,253,245 | May 1, 2023 | March 31, 2028 | DE NADAI, ALESSANDRO STEVENS | reporter.nih.gov |
| Autophagic regulation of cocaine abuse | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,222,317 | August 15, 2022 | May 31, 2027 | HE, CONGCONG | reporter.nih.gov |
| Glial-mediated synaptic remodeling in drug addiction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,202,322 | June 1, 2016 | April 30, 2027 | DONG, YAN | reporter.nih.gov |
| Circadian Rhythms and Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,173,145 | August 1, 2021 | May 31, 2026 | FERRIS, MARK J | reporter.nih.gov |
| Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,161,166 | September 30, 2023 | July 31, 2028 | ZHU, JIAN | reporter.nih.gov |
| Cocaine, Parvalbumin, and Perineuronal Nets | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,155,184 | April 1, 2023 | January 31, 2028 | SORG, BARBARA A | reporter.nih.gov |
| 5-HT2 Receptor Allosterism in Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,154,204 | August 1, 2015 | April 30, 2027 | ZHOU, JIA | reporter.nih.gov |
| Cocaine-induced adaptation in NMDA receptors | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,139,400 | December 1, 2022 | November 30, 2027 | DONG, YAN | reporter.nih.gov |
| Comorbidities and other consequences at the intersection of the HIV and substance use epidemics | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,110,949 | September 1, 2023 | June 30, 2028 | CRANE, HEIDI M. | reporter.nih.gov |
| Inflammasome activation in an SIV-ART model of chronic drug abuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,104,458 | September 30, 2019 | July 31, 2025 | VEENHUIS, REBECCA TERILLI | reporter.nih.gov |
| Individual Differences & Cocaine Effects on Impulsive Choice in Rat | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,102,499 | July 1, 2016 | March 31, 2027 | TAYLOR, JANE R | reporter.nih.gov |
| Immune mechanisms that shape the blood brain barrier in people living with HIV and cocaine use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,096,862 | June 1, 2024 | March 31, 2029 | VEENHUIS, REBECCA TERILLI | reporter.nih.gov |
| Benzodiazepine Choice and Polydrug Use | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,074,200 | April 1, 2022 | January 31, 2027 | HUSKINSON, SALLY L | reporter.nih.gov |
| New psychoactive substance exposure among NYC nightclub and festival attendees | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,051,804 | August 15, 2023 | May 31, 2027 | PALAMAR, JOSEPH J | reporter.nih.gov |
| Dopaminergic and Glutamatergic Mechanisms of Cocaine Addiction: Sex Differences | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,046,903 | April 1, 2008 | May 31, 2027 | LYNCH, WENDY JEAN | reporter.nih.gov |
| Targeting gut brain-signaling to reduce cocaine seeking behaviors | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,040,985 | September 1, 2023 | June 30, 2028 | KIRALY, DREW | reporter.nih.gov |
| Retinoic acid, homeostatic plasticity and cocaine craving | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,026,004 | March 15, 2020 | December 31, 2025 | WOLF, MARINA ELIZABETH | reporter.nih.gov |
| Neural mechanisms regulating cocaine consumption | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,000,599 | July 15, 2020 | April 30, 2026 | PHILLIPS, PAUL E. M. | reporter.nih.gov |
| Mitochondrial signaling dynamics in cocaine use disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,977,342 | August 15, 2023 | June 30, 2028 | ABRAHAM, ANTONY DANIEL | reporter.nih.gov |
| Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE) | NIH | National Institute on Drug Abuse | 2025 | $1,969,877 | July 15, 2025 | March 31, 2030 | TIEN, PHYLLIS C | reporter.nih.gov |
| Novel Addiction Neurocircuits in Cocaine Taking | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,955,360 | April 1, 2022 | January 31, 2027 | HOMMEL, JONATHAN DEAN | reporter.nih.gov |
| Examining predictors of substance use and treatment adequacy among formerly incarcerated opiod and cocaine users | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,937,137 | August 1, 2022 | June 30, 2027 | ROWELL-CUNSOLO, TAWANDRA LASHONE | reporter.nih.gov |
| Regulation of striatal microcircuits by endogenous opioids as a novel mechanism underlying cocaine seeking | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,936,984 | August 1, 2022 | May 31, 2027 | DOBBS, LAUREN K | reporter.nih.gov |
| Cocaine: effects on single neurons | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,925,000 | July 1, 1987 | July 31, 2027 | WILLIAMS, JOHN T | reporter.nih.gov |
| SARS-CoV-2 signaling and interactions with stimulant drugs of abuse via Sigma-1R: Impact on the BBB | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,914,927 | July 1, 2022 | April 30, 2027 | UNTERWALD, ELLEN M | reporter.nih.gov |
| Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,904,596 | September 30, 2019 | July 31, 2025 | BUCH, SHILPA J. | reporter.nih.gov |
| Pioglitazone as an adjunct to CBT for cocaine relapse prevention | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,864,756 | July 1, 2020 | May 31, 2025 | SCHMITZ, JOY MARIE | reporter.nih.gov |
| Glutamergic Mechanisms in Opioid and Cocaine Co-Use | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,854,763 | September 30, 2020 | August 31, 2025 | GIPSON-REICHARDT, CASSANDRA D | reporter.nih.gov |
| Incubated drug-craving and neurochemical interactions | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,780,211 | April 15, 2021 | December 31, 2025 | SZUMLINSKI, KAREN KATHLEEN | reporter.nih.gov |
| Neural systems mediating the extinction and inhibition of cocaine seeking | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,771,684 | July 15, 2020 | April 30, 2026 | LALUMIERE, RYAN T | reporter.nih.gov |
| Mechanisms underlying the influence of stress on drug-seeking behavior | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,764,926 | July 1, 2023 | April 30, 2028 | MANTSCH, JOHN R | reporter.nih.gov |
| Calcium-related neurotoxicity of cocaine | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,729,326 | February 15, 2012 | January 31, 2027 | DU, CONGWU | reporter.nih.gov |
| Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,726,798 | July 1, 2013 | April 30, 2025 | ZHU, JUN | reporter.nih.gov |
| Hippocampal mechanisms of cocaine-memory reconsolidation | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,719,615 | June 1, 2023 | March 30, 2028 | FUCHS LOKENSGARD, RITA A | reporter.nih.gov |
| PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,708,450 | August 15, 2020 | April 30, 2027 | BAKER, DAVID A | reporter.nih.gov |
| Nitrergic interneurons and cue-induced cocaine seeking | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,697,532 | August 1, 2021 | May 31, 2027 | SCOFIELD, MICHAEL DAVID | reporter.nih.gov |
| Genetic and hormonal contributions to sex differences in vulnerability to drug use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,691,545 | March 1, 2020 | December 31, 2025 | LYNCH, WENDY JEAN | reporter.nih.gov |
| Nature and Predictors of Impaired Harm Avoidance in Polysubstance Abuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,690,491 | July 1, 2018 | June 30, 2026 | OTTO, MICHAEL W. | reporter.nih.gov |
| Diurnal rhythms in the nucleus accumbens: Mechanisms and role in substance use disorders | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,678,144 | July 1, 2015 | March 31, 2026 | MCCLUNG, COLLEEN A | reporter.nih.gov |
| Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,677,906 | August 15, 2018 | May 31, 2024 | SILICIANO, ROBERT F | reporter.nih.gov |
| Cognitive Reappraisal for Mitigating Incubation of Cocaine Cue-Reactivity | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,675,624 | September 30, 2023 | August 31, 2028 | PARVAZ, MUHAMMAD ADEEL | reporter.nih.gov |
| Assessing central muscarinic acetylcholine type-1 receptors in cocaine use disorder with 11C-LSN3172176. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,664,691 | April 15, 2022 | June 30, 2027 | ANGARITA, GUSTAVO ADOLFO | reporter.nih.gov |
| Non-beta-lactam GLT-1 activators: characterization in preclinical models of opioid and cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,661,677 | September 30, 2020 | June 30, 2025 | RAWLS, SCOTT M. | reporter.nih.gov |
| Circuitry and function of ventral striatum subregions | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,660,649 | April 1, 2020 | January 31, 2026 | WESSON, DANIEL W | reporter.nih.gov |
| Memory Destabilization and Cocaine-Cue Induced Reinstatement in Rat | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,653,750 | July 1, 2021 | April 30, 2027 | TAYLOR, JANE R | reporter.nih.gov |
| L-Type Calcium Channel Mechanisms Mediating Comorbid Substance Use and Mood Disorders | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,645,542 | September 30, 2020 | July 31, 2025 | ADDY, NII A | reporter.nih.gov |
| Development of selective cannabinoid receptor 2 agonists for treatment of addiction | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,621,997 | April 19, 2022 | April 30, 2027 | SHAMLOO, MEHRDAD | reporter.nih.gov |
| Epigenetic regulation of Cdk5 in cognition and emotion | NIH | National Institute of Mental Health | 2023 to 2025 | $1,621,522 | January 1, 2023 | October 31, 2027 | HELLER, ELIZABETH A | reporter.nih.gov |
| Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2022 | $1,597,923 | September 30, 2022 | September 29, 2025 | BJORK, JAMES M | reporter.nih.gov |
| Transgenerational Inheritance of a Cocaine Resistance Phenotype | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,594,735 | April 1, 2012 | January 31, 2027 | PIERCE, ROBERT CHRISTOPHER | reporter.nih.gov |
| Cholinergic interneuron D2 receptor function in impulsive behavior: implications for addiction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,571,833 | July 1, 2022 | May 31, 2027 | GALLO, EDUARDO FRANCISCO | reporter.nih.gov |
| Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,555,079 | September 30, 2019 | July 31, 2024 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| Vagus nerve stimulation modulates synaptic plasticity in the rat prefrontal cortex during the extinction of drug-seeking | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,554,112 | April 1, 2022 | January 31, 2027 | KROENER, SVEN | reporter.nih.gov |
| Genetic Control of Addiction by Host and Microbiome | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,533,193 | September 30, 2018 | July 31, 2024 | BUBIER, JASON A | reporter.nih.gov |
| Domain- and protein-selective BET mechanisms in cocaine-seeking behaviors | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,521,368 | August 1, 2023 | May 31, 2028 | SARTOR, GREGORY CHARLES | reporter.nih.gov |
| Effects of intrinsic and drug-induced neuromodulation on functional brain imaging | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,517,943 | August 1, 2020 | May 31, 2025 | DEVOR, ANNA | reporter.nih.gov |
| Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,515,246 | August 15, 2021 | June 30, 2024 | GUO, MINGLEI | reporter.nih.gov |
| Restoration and Further Assessment of the Actor-Critic Circuit and Connected Areas After Cocaine Self-Administration | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,495,707 | July 1, 2011 | February 29, 2028 | ROESCH, MATTHEW R | reporter.nih.gov |
| A novel opioid receptor antagonist for treating abuse and overdose | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,477,314 | April 1, 2019 | February 28, 2025 | FRANCE, CHARLES P | reporter.nih.gov |
| Glutamate and Craving for Cocaine | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,472,920 | February 10, 2000 | March 31, 2025 | KALIVAS, PETER W | reporter.nih.gov |
| Examining Mechanisms Underlying Drug-Associated Memory Erasure by Zeta-Inhibitory Peptide | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,470,367 | April 15, 2019 | January 31, 2025 | BRIAND, LISA A | reporter.nih.gov |
| Systems genetics of premorbid and cocaine use traits in a rat reduced complexity cross | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,444,164 | May 1, 2022 | December 31, 2023 | KANTAK, KATHLEEN M. | reporter.nih.gov |
| Bath Salts: abuse-related and toxic effects | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,439,490 | April 1, 2015 | March 31, 2026 | COLLINS, GREGORY THOMAS | reporter.nih.gov |
| Dissecting the role of ventral pallidal circuitry in cocaine seeking after the withdrawal | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,425,586 | July 15, 2020 | April 30, 2025 | LIM, BYUNGKOOK | reporter.nih.gov |
| Neural Mechanisms of Individual Differences in Cocaine Avoidance | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,404,531 | August 1, 2021 | May 31, 2026 | JHOU, THOMAS C | reporter.nih.gov |
| Impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIV | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,402,812 | September 30, 2024 | May 31, 2029 | JIANG, WEI | reporter.nih.gov |
| Modulating ventral striatal activity and connectivity with transcranial focused ultrasound as a putative novel intervention for cocaine use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,395,182 | June 15, 2024 | May 31, 2027 | PHILLIPS, MARY LOUISE | reporter.nih.gov |
| Selective Targeting of Nicotinic Acetylcholine Receptor Subtypes for Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,393,000 | March 1, 2024 | December 31, 2028 | RILEY, ANDREW | reporter.nih.gov |
| Estrogen regulation of the prefrontal cortex and drug seeking | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,390,995 | July 1, 2020 | April 30, 2026 | MANTSCH, JOHN R. | reporter.nih.gov |
| Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,377,622 | August 15, 2018 | May 31, 2025 | JOHNSON, ERIC OTTO | reporter.nih.gov |
| Sleep Disturbances During Cocaine Abstinence, Dopamine Adaptations, and Motivation for Cocaine | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,375,686 | May 1, 2023 | February 29, 2028 | ESPAÑA, RODRIGO A. | reporter.nih.gov |
| Animal Models of Addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,368,000 | December 1, 2018 | November 30, 2024 | FERRARIO, CARRIE | reporter.nih.gov |
| Pathway-specific Intervention in Prelimbic Cortical Circuitry Decreases Cocaine-seeking | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,357,969 | September 30, 2020 | July 31, 2025 | MCGINTY, JACQUELINE F. | reporter.nih.gov |
| Regulating dopamine transport through allosteric modulation - Functional and Behavioral Studies | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,337,160 | September 15, 2024 | May 31, 2029 | MORTENSEN, OLE VALENTE | reporter.nih.gov |
| Dissecting the shared genetic mechanisms driving fentanyl addiction, cocaine addiction, and incentive sensitization using the Collaborative Cross mouse panel | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,331,986 | June 1, 2024 | March 31, 2029 | DICKSON, PRICE EVANS | reporter.nih.gov |
| CELL - AND CIRCUIT - SPECIFIC EXPLORATION OF HIV NEUROGENOMICS IN CONTEXT OF OPIATE AND COCAINE ABUSE | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,327,322 | June 1, 2019 | March 31, 2026 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Systems genetics of premorbid and cocaine use traits in a rat reduced complexity cross | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,325,341 | March 7, 2024 | February 28, 2028 | BRYANT, CAMRON D | reporter.nih.gov |
| Involvement of Cortical Excitatory Projections in Cocaine Addiction | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,324,728 | September 30, 2024 | May 31, 2029 | MA, YAO-YING | reporter.nih.gov |
| Microglial modulation of neurocircuits in HIV/cocaine comorbidity | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,323,376 | June 1, 2023 | March 31, 2025 | BOOZE, ROSEMARIE M | reporter.nih.gov |
| A cutaneous gene therapy for cocaine abuse and alcohol co-abuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,312,200 | September 30, 2019 | July 31, 2025 | XU, MING | reporter.nih.gov |
| Ventral pallidum molecular mediators in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,302,852 | February 1, 2019 | November 30, 2024 | LOBO, MARY KAY | reporter.nih.gov |
| Opioid and Psychostimulant Taking: Testing the Impact of Behavioral Economic Contexts | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,280,955 | September 15, 2022 | July 31, 2027 | KEARNS, DAVID N | reporter.nih.gov |
| Influence of 5-HT1b Activation on the Abuse Related Effects of Cocaine | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,280,534 | August 1, 2021 | July 31, 2025 | STOOPS, WILLIAM WALTON | reporter.nih.gov |
| HIV and cocaine use leads to loss of astrocyte neurotrophic support and impaired lipid homeostasis in the brain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,272,487 | September 20, 2022 | August 31, 2026 | LANGFORD, DIANNE TERESA | reporter.nih.gov |
| Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,241,165 | September 1, 2017 | May 31, 2024 | EVANS, SUZETTE M | reporter.nih.gov |
| Human dopamine transporter gene: variation and transcriptional regulation | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,230,000 | September 1, 2007 | July 31, 2025 | LIN, ZHICHENG CARL | reporter.nih.gov |
| Genomic Analysis of Avoidance Learning in Addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,223,491 | April 15, 2018 | June 4, 2023 | JHOU, THOMAS C | reporter.nih.gov |
| A translational determination of the mechanisms of maladaptive choice in cocaine use disorder | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,222,073 | July 1, 2018 | April 30, 2024 | LILE, JOSHUA ANTHONY | reporter.nih.gov |
| Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,218,955 | February 1, 2024 | January 31, 2028 | BLACKWELL, KIM L | reporter.nih.gov |
| Diagnostic and prognostic biomarkers for subtypes of addiction-related circuit dysfunction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,207,946 | August 1, 2019 | May 31, 2024 | LISTON, CONOR M | reporter.nih.gov |
| Low-intensity focused ultrasound for cocaine use disorder: High resolution targeting of the human insula | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,197,126 | August 1, 2022 | January 31, 2025 | AIT-DAOUD, NASSIMA | reporter.nih.gov |
| The role of central GLP-1 receptors in animal models of cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,188,835 | March 1, 2015 | May 31, 2025 | SCHMIDT, HEATH D | reporter.nih.gov |
| Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,185,000 | September 30, 2016 | July 31, 2028 | TAFFE, MICHAEL A. | reporter.nih.gov |
| Dissection of Addiction Relevant Signal Integration by Cyfip2 through Precise Genome Engineering | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,178,521 | July 15, 2020 | June 30, 2025 | KUMAR, VIVEK | reporter.nih.gov |
| A2: Striosomal models of drug use and cost | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,173,870 | September 15, 2024 | May 31, 2029 | FRIEDMAN, ALEXANDER | reporter.nih.gov |
| Mechanistic studies of alcohol-sleep interactions | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,173,750 | September 17, 2019 | August 31, 2025 | TORREGROSSA, MARY M | reporter.nih.gov |
| Neuronal exosomes in cocaine abuse and treatment response in socially housed monkeys | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,162,500 | July 1, 2019 | April 30, 2025 | DEEP, GAGAN | reporter.nih.gov |
| Molecular determinants of ensemble recruitment by drugs of abuse | NIH | National Institute on Drug Abuse | 2025 | $1,159,396 | July 1, 2025 | March 31, 2030 | CALIPARI, ERIN | reporter.nih.gov |
| Novel 5-HT2A/mGluR5 Antagonist for Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $1,153,945 | September 15, 2025 | August 31, 2027 | MOELLER, FREDERICK GERARD | reporter.nih.gov |
| Identifying patterns of human polysubstance use to guidedevelopment of rodent models | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,138,416 | September 30, 2018 | June 30, 2024 | KNACKSTEDT, LORI A | reporter.nih.gov |
| Establishing a link between habits and punishment resistance | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,106,838 | February 15, 2019 | December 31, 2025 | SMITH, RACHEL J | reporter.nih.gov |
| Zona Incerta Contributions to Reward and Cocaine Addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,097,250 | September 15, 2019 | June 30, 2025 | LIU, QING-SONG | reporter.nih.gov |
| Functional consequences of cocaine self-administration on astrocytes | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,086,725 | May 1, 2023 | February 29, 2028 | REISSNER, KATHRYN JOANNA | reporter.nih.gov |
| Multimodal profiling of microglia during HIV infection and substance use disorder | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,076,164 | September 30, 2023 | August 31, 2025 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Developing a sleep EEG-based biomarker for drug relapse propensity | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,075,270 | April 15, 2024 | January 31, 2029 | HUANG, YANHUA H | reporter.nih.gov |
| ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTION | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,067,550 | August 1, 1992 | November 30, 2025 | ASTON-JONES, GARY S. | reporter.nih.gov |
| Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,065,924 | September 1, 2023 | August 31, 2025 | ZHENG, FANG | reporter.nih.gov |
| Investigating the mechanistic contribution of Cav1.2 channels in extinction of cocaine-associated memories | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,063,494 | April 1, 2022 | October 31, 2023 | RAJADHYAKSHA, ANJALI M | reporter.nih.gov |
| Mechanistic studies of cAMP effectors in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,062,600 | April 15, 2014 | May 31, 2025 | LIU, QING-SONG | reporter.nih.gov |
| Sleep regulates drug relapse and addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,056,375 | April 1, 2019 | January 31, 2025 | HUANG, YANHUA H | reporter.nih.gov |
| Encoding dopamine signals in the mesolimbic system | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,049,625 | August 1, 2013 | February 28, 2025 | FORD, CHRISTOPHER PETER | reporter.nih.gov |
| ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTION | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,048,129 | August 1, 1992 | November 30, 2022 | ASTON-JONES, GARY S. | reporter.nih.gov |
| Pharmacology of Stimulant Choice | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,047,939 | April 15, 2023 | February 29, 2028 | BANKS, MATTHEW L | reporter.nih.gov |
| Extensive drug histories result in compulsive appetite: functional identification of punishment-reactive neural network re-organization in the rostromedial tegmental nucleus | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,042,506 | September 1, 2022 | April 26, 2024 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Reprogramming KZFP function to understand drug-specific transcription and behavior | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,040,268 | May 1, 2024 | February 28, 2029 | HAMILTON, PETER JAMES | reporter.nih.gov |
| Investigating the mechanistic contribution of Cav1.2 channels in extinction of cocaine-associated memories | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,031,426 | July 1, 2020 | January 31, 2027 | RAJADHYAKSHA, ANJALI M | reporter.nih.gov |
| Neural Mechanisms of Individual Differences in Cocaine Avoidance | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,031,082 | August 1, 2021 | May 31, 2023 | JHOU, THOMAS C | reporter.nih.gov |
| Characterization of cortical neuronal subtypes in cocaine self-administration | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,029,911 | August 15, 2019 | May 31, 2023 | FERGUSON, SUSAN MARIE | reporter.nih.gov |
| Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,013,596 | April 1, 2019 | January 31, 2024 | STEINER, HEINZ | reporter.nih.gov |
| Transgenerational Inheritance of a Cocaine Resistance Phenotype | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,009,002 | April 1, 2012 | January 31, 2023 | PIERCE, ROBERT CHRISTOPHER | reporter.nih.gov |
| The Genetic and Epigenetic Interplay of Cocaine Addiction: A Cell-Type, Circuitry, and Functional Dissection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $984,000 | August 1, 2024 | June 30, 2029 | ZHANG, ZHUZHU | reporter.nih.gov |
| Cyclic Peptides to Treat Cocaine Use Disorder | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $981,998 | May 15, 2023 | April 30, 2026 | ALDRICH, JANE V | reporter.nih.gov |
| Differential Roles of Prefrontal Cortical Interneurons in Drug Seeking after Withdrawal | NIH | National Institute on Drug Abuse | 2024 to 2025 | $972,206 | July 1, 2024 | April 30, 2029 | LIM, BYUNGKOOK | reporter.nih.gov |
| Hypocretinergic control of cocaine abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $964,962 | September 30, 2018 | June 30, 2023 | HORVATH, TAMAS L | reporter.nih.gov |
| Regulation of monoamine neurons by delta glutamate receptors | NIH | National Institute on Drug Abuse | 2024 to 2025 | $961,242 | April 1, 2024 | January 31, 2029 | GANTZ, STEPHANIE C. | reporter.nih.gov |
| Epitranscriptomic Regulation of Synaptic Responses to Drugs of Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $954,795 | July 15, 2018 | June 30, 2024 | MEYER, KATHRYN D | reporter.nih.gov |
| Cyclic Peptides to Treat Cocaine Use Disorder | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $945,491 | May 15, 2023 | April 30, 2024 | ALDRICH, JANE V | reporter.nih.gov |
| Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats | NIH | National Institute on Drug Abuse | 2025 | $944,888 | July 1, 2025 | March 31, 2030 | MOHAMMADI, PEJMAN | reporter.nih.gov |
| Mentoring patient-oriented research on the health consequences of polydrug use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $941,480 | July 1, 2015 | June 30, 2027 | RILEY, ELISE D. | reporter.nih.gov |
| Extensive drug histories result in compulsive appetite: functional identification of punishment-reactive neural network re-organization in the rostromedial tegmental nucleus | NIH | National Institute on Drug Abuse | 2024 to 2025 | $939,600 | July 15, 2024 | June 30, 2027 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Cocaine Abstinence or Reduced Use May Retard Alterations in Brain Structure and Function, and Associated Cognitive Changes among African American Cocaine Users with HIV | NIH | National Institute on Drug Abuse | 2024 | $939,459 | May 1, 2024 | February 28, 2029 | LAI, SHENGHAN | reporter.nih.gov |
| Characterization of cocaine induced signaling pathways that enhances HIV transcription | NIH | National Institute on Drug Abuse | 2021 to 2023 | $916,120 | September 1, 2017 | April 30, 2026 | TYAGI, MUDIT | reporter.nih.gov |
| Examination of epigenetic spatial architecture in the CNS as a method to understand cocaine relapse in ecoHIV infected mice | NIH | National Institute on Drug Abuse | 2024 to 2025 | $908,940 | September 30, 2024 | November 30, 2026 | KLASE, ZACHARY ALAN | reporter.nih.gov |
| Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis | NIH | National Institute on Drug Abuse | 2025 | $898,025 | April 15, 2025 | February 28, 2030 | BYRAREDDY, SIDDAPPA N | reporter.nih.gov |
| Chemokine CXCL12/CXCR4 system and synthetic cathinones | NIH | National Institute on Drug Abuse | 2021 to 2022 | $894,344 | July 1, 2018 | April 30, 2024 | RAWLS, SCOTT M. | reporter.nih.gov |
| High-throughput identification and characterization of conserved regulators of drug-induced plasticity using single-neuron resolution atlases of the complete Caenorhabditis elegans nervous system | NIH | National Institute on Drug Abuse | 2024 to 2025 | $891,000 | September 30, 2024 | July 31, 2029 | SUN, HAOSHENG | reporter.nih.gov |
| Elucidating Ih Biophysical Epigenetic Modifications in VTA Dopaminergic Neurons after Contingent and Non-Contingent Cocaine Administration | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $884,337 | July 15, 2022 | June 30, 2027 | JIMENEZ-RIVERA, CARLOS A | reporter.nih.gov |
| Retinoic acid signaling: a novel factor for addiction-related behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $864,126 | September 15, 2018 | June 30, 2024 | GREEN, THOMAS ARTHUR | reporter.nih.gov |
| Assessing central muscarinic acetylcholine type-1 receptors in cocaine use disorder with 11C-LSN3172176. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $837,270 | April 15, 2022 | June 30, 2024 | WORHUNSKY, PATRICK D | reporter.nih.gov |
| Cognitively-enhanced tDCS of the dorsolateral prefrontal cortex to reduce craving in cocaine addiction | NIH | National Institute on Drug Abuse | 2025 | $833,825 | May 1, 2025 | February 28, 2030 | GOLDSTEIN, RITA Z | reporter.nih.gov |
| Role of prelimbic cortical endocannabinoid signaling in enhanced cocaine-seeking behavior following combined repeated stress and cocaine use in rats | NIH | National Institute on Drug Abuse | 2024 to 2025 | $832,475 | March 1, 2024 | January 31, 2029 | MCREYNOLDS, JAYME ROSE | reporter.nih.gov |
| Expanding the Scope and Usability of Fast Voltammetric Measurements | NIH | National Institute on Drug Abuse | 2024 to 2025 | $832,134 | September 15, 2024 | July 31, 2029 | SOMBERS, LESLIE A | reporter.nih.gov |
| The Sex-specific Roles and Neural Processing Correlates of Future Outcome Estimation in the Drug Addiction Process | NIH | National Institute on Drug Abuse | 2021 to 2022 | $822,627 | July 1, 2018 | April 30, 2024 | JAMES, GEORGE ANDREW | reporter.nih.gov |
| B1 noradrenergic blockade in early withdrawal to reduce cocaine induced behavioral flexibility deficit | NIH | National Institute on Drug Abuse | 2021 to 2022 | $818,813 | March 1, 2020 | February 29, 2024 | WEST, ELIZABETH A | reporter.nih.gov |
| Short-term Outcome of Stimulant Use Disorder Treatment Trials | NIH | National Institute on Drug Abuse | 2022 to 2023 | $818,750 | August 1, 2022 | January 31, 2024 | MOJTABAI, RAMIN | reporter.nih.gov |
| Basolateral amygdala dopamine in addiction-related learning strategies | NIH | National Institute on Drug Abuse | 2024 to 2025 | $818,513 | September 15, 2024 | May 31, 2029 | SAUNDERS, BENJAMIN THOMAS | reporter.nih.gov |
| Cognitive Reappraisal for Mitigating Incubation of Cocaine Cue-Reactivity | NIH | National Institute on Drug Abuse | 2023 | $815,875 | September 30, 2023 | August 31, 2028 | PARVAZ, MUHAMMAD ADEEL | reporter.nih.gov |
| Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $807,872 | September 1, 2017 | June 30, 2023 | PELTZ, GARY A | reporter.nih.gov |
| Genetic substrates of cue-reactivity and cocaine motivation | NIH | National Institute on Drug Abuse | 2025 | $802,735 | August 1, 2025 | April 30, 2030 | MEYER, PAUL J | reporter.nih.gov |
| Discovery of GPR52 ligand probes for cocaine use disorder | NIH | National Institute on Drug Abuse | 2025 | $795,090 | September 1, 2025 | May 31, 2030 | ALLEN, JOHN A | reporter.nih.gov |
| Reversing Cocaine-induced Impairments in the NAc with Controllable Stressors | NIH | National Institute on Drug Abuse | 2021 to 2022 | $782,589 | September 30, 2018 | August 31, 2024 | SADDORIS, MICHAEL | reporter.nih.gov |
| Novel anti-cocaine D1 partial agonists | NIH | National Institute on Drug Abuse | 2021 to 2022 | $780,000 | May 1, 2019 | April 30, 2024 | HARDING, WAYNE WESLEY | reporter.nih.gov |
| Analyzing Sequential, Multiple Assignment, Randomized Trials in the Presence of Partial Compliance | NIH | National Institute on Drug Abuse | 2021 to 2022 | $769,466 | September 30, 2019 | August 31, 2024 | ERTEFAIE, ASHKAN | reporter.nih.gov |
| Addiction liability, poor attentional control, and cholinergic deficiency | NIH | National Institute on Drug Abuse | 2021 to 2022 | $768,539 | September 15, 2018 | June 30, 2023 | SARTER, MARTIN F | reporter.nih.gov |
| THE ROLE OF RYANODINE RECEPTORS IN DRUG SEEKING | NIH | National Institute on Drug Abuse | 2021 to 2022 | $767,162 | July 15, 2018 | May 31, 2024 | RIEGEL, ARTHUR C | reporter.nih.gov |
| Cocaine Addition and the Need-State Hypothesis | NIH | National Institute on Drug Abuse | 2025 | $762,063 | May 1, 2025 | February 28, 2030 | GRIGSON, PATRICIA SUE | reporter.nih.gov |
| NOP receptors as targets for novel pharmacotherapies for cocaine use disorder in nonhuman primate models | NIH | National Institute on Drug Abuse | 2025 | $758,218 | September 1, 2025 | May 31, 2030 | CZOTY, PAUL W. | reporter.nih.gov |
| Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | NIH | National Institute on Drug Abuse | 2024 to 2025 | $751,970 | August 15, 2021 | June 30, 2027 | GUO, MINGLEI | reporter.nih.gov |
| Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $747,910 | April 15, 2019 | January 31, 2024 | ISAACS, LYLE D | reporter.nih.gov |
| Role of Class IIa HDAC Target Genes in Opioid and Cocaine Addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $747,500 | July 1, 2013 | May 31, 2024 | COWAN, CHRISTOPHER W | reporter.nih.gov |
| Sex Differences in Addiction | NIH | National Institute on Drug Abuse | 2022 to 2024 | $747,000 | March 1, 2019 | February 28, 2026 | KOHTZ, AMY | reporter.nih.gov |
| Effects of exercise on dopaminergic mechanisms of cocaine relapse | NIH | National Institute on Drug Abuse | 2022 to 2024 | $746,997 | August 1, 2019 | February 28, 2026 | ZLEBNIK, NATALIE | reporter.nih.gov |
| Circuit Mechanisms for Conditioned Stress Regulation of Addiction | NIH | National Institute on Drug Abuse | 2022 to 2024 | $746,997 | July 15, 2019 | June 30, 2026 | GARCIA KELLER, CONSTANZA | reporter.nih.gov |
| Orexin (hypocretin) signaling in ventral tegmental area as a common mediator of sleep disturbances and drug demand in cocaine abstinence | NIH | National Institute on Drug Abuse | 2024 to 2025 | $745,734 | July 15, 2024 | May 31, 2029 | ASTON-JONES, GARY S. | reporter.nih.gov |
| Neural circuitry of distress tolerance | NIH | National Institute on Drug Abuse | 2021 to 2023 | $745,315 | March 1, 2019 | February 28, 2025 | MOSCHAK, TRAVIS M | reporter.nih.gov |
| Role of Nucleus Accumbens D2-expressing Neurons in Punished Cocaine Seeking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $744,648 | April 1, 2019 | April 30, 2025 | VENTO, PETER J. | reporter.nih.gov |
| Multimodal profiling of microglia during HIV infection and substance use disorder | NIH | National Institute on Drug Abuse | 2025 | $744,484 | September 30, 2023 | August 31, 2028 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Reinforcement | NIH | National Institute on Drug Abuse | 2021 to 2022 | $742,144 | January 1, 2013 | May 31, 2025 | ESPAÑA, RODRIGO A. | reporter.nih.gov |
| Unpredictable availability as a determinant of drug-related outcomes | NIH | National Institute on Drug Abuse | 2021 to 2022 | $736,250 | April 1, 2018 | March 31, 2025 | HUSKINSON, SALLY | reporter.nih.gov |
| Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder | NIH | National Institute on Drug Abuse | 2023 | $728,927 | May 15, 2023 | April 30, 2027 | MARTINEZ, DIANA M | reporter.nih.gov |
| Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine | NIH | National Institute on Drug Abuse | 2025 | $728,575 | May 15, 2025 | April 30, 2029 | ZHU, JUN | reporter.nih.gov |
| Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances | NIH | National Institute on Drug Abuse | 2022 to 2024 | $724,401 | September 1, 2022 | July 31, 2026 | FLETCHER, JESSE BRADFORD | reporter.nih.gov |
| Mechanisms underlying dysregulated neuroimmune signaling and neuronal dysfunction in HIV (+) individuals with cART and cocaine | NIH | National Institute on Drug Abuse | 2021 to 2022 | $724,376 | September 30, 2018 | July 31, 2025 | BUCH, SHILPA J. | reporter.nih.gov |
| Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study | NIH | National Institute on Drug Abuse | 2025 | $702,965 | June 15, 2025 | February 28, 2029 | YAMMINE, LUBA | reporter.nih.gov |
| Effect of Mindfulness Training on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment | NIH | National Center for Complementary & Integrative Health | 2022 | $700,000 | July 1, 2022 | August 31, 2024 | SCHUMAN OLIVIER, ZEV DAVID | reporter.nih.gov |
| Relevance and plasticity of inhibitory metabotropic signaling in reward circuits | NIH | National Institute on Drug Abuse | 2021 to 2022 | $688,500 | August 1, 2013 | February 28, 2023 | WICKMAN, KEVIN D | reporter.nih.gov |
| Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal | NIH | National Institute on Drug Abuse | 2022 | $685,732 | June 1, 2017 | March 31, 2025 | MCCAUL, MARY E | reporter.nih.gov |
| Social Influences on Drug-Seeking Behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $685,534 | April 1, 2012 | July 31, 2025 | SMITH, MARK A | reporter.nih.gov |
| Neuron subtype specific role of DNA methylcytosine dioxygenase TET1 in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $681,815 | September 15, 2018 | June 30, 2024 | FENG, JIAN | reporter.nih.gov |
| Development of selective cannabinoid receptor 2 agonists for treatment of addiction | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $661,980 | April 19, 2022 | March 31, 2023 | SHAMLOO, MEHRDAD | reporter.nih.gov |
| Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity | NIH | National Institute on Drug Abuse | 2023 | $652,413 | April 15, 2023 | August 11, 2023 | BLACKWELL, KIM L | reporter.nih.gov |
| The Influence of Gonadal Hormones on Opioid Use | NIH | National Institute on Drug Abuse | 2021 to 2022 | $651,443 | September 30, 2018 | July 31, 2024 | SMITH, MARK A | reporter.nih.gov |
| The role of GPER-1 and addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $649,193 | September 30, 2020 | July 31, 2024 | BECKER, JILL B. | reporter.nih.gov |
| Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $643,949 | September 1, 2023 | August 31, 2028 | ZHENG, FANG | reporter.nih.gov |
| Psilocybin-Assisted Treatment of Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $643,019 | July 15, 2025 | June 30, 2027 | ARIAS, ALBERT JOSEPH | reporter.nih.gov |
| HIV and Cocaine Use Leads to Loss of Astrocyte Neurotrophic Support and Impaired Lipid Homeostasis in the Brain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $627,502 | September 20, 2022 | May 31, 2027 | LANGFORD, DIANNE TERESA | reporter.nih.gov |
| Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study with Pentoxifylline | NIH | National Institute on Drug Abuse | 2025 | $620,383 | July 1, 2025 | February 29, 2028 | STOOPS, WILLIAM WALTON | reporter.nih.gov |
| Norepinephrine modulates medial prefrontal cortex neural ensembles that control cocaine seeking behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $586,321 | December 12, 2022 | May 31, 2027 | GHEIDI, ALI | reporter.nih.gov |
| Cell-Types Specific Neuroadaptations in the Nucleus Accumbens Shell Associated with Individual Differences in Cocaine-Seeking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $580,446 | September 30, 2021 | September 2, 2023 | CARRERO, JEFFREY PARRILLA | reporter.nih.gov |
| Chromatin regulation of neuronal activity-induced enhancer priming and epigenetic memory | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $578,632 | March 1, 2025 | December 31, 2029 | WU, JIANG | reporter.nih.gov |
| Understanding the role of paraventricular neurotensin neurons in valence processing | NIH | National Institute on Drug Abuse | 2024 to 2025 | $577,653 | February 1, 2022 | January 31, 2027 | LI, HAO | reporter.nih.gov |
| Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use | NIH | National Institute on Drug Abuse | 2022 | $574,367 | September 1, 2017 | November 30, 2024 | STOOPS, WILLIAM WALTON | reporter.nih.gov |
| TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939 | NIH | National Institute on Drug Abuse | 2023 | $571,190 | September 12, 2023 | September 11, 2024 | AROLFO , MARIA | reporter.nih.gov |
| HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2022 | $570,030 | April 1, 2022 | October 26, 2023 | ANDREWS, ALLISON MICHELLE | reporter.nih.gov |
| Nucleus accumbens neuronal ensembles in drugs and natural rewards seeking. | NIH | National Institute on Drug Abuse | 2021 to 2023 | $564,842 | December 1, 2020 | August 16, 2023 | BATCHELDER, ABIGAIL | reporter.nih.gov |
| HIV and cocaine mediated lipid dysregulation in microglia: Immunometabolism mechanisms underlying NeuroHIV | NIH | National Institute on Drug Abuse | 2025 | $563,742 | July 15, 2025 | May 31, 2030 | GUO, MINGLEI | reporter.nih.gov |
| The role of neuronal ensemble Rac1 activity in cocaine seeking behavior | NIH | National Institute on Drug Abuse | 2024 | $563,694 | July 15, 2024 | April 30, 2025 | WARREN, BRANDON L | reporter.nih.gov |
| MRI data fusion to investigate effects of drug abuse on HIV neurological complications | NIH | National Institute on Drug Abuse | 2021 to 2022 | $556,750 | March 15, 2018 | June 30, 2023 | MEADE, CHRISTINA S | reporter.nih.gov |
| Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $547,813 | July 1, 2023 | June 30, 2028 | WEBBER, HEATHER E | reporter.nih.gov |
| The role of neuroactive steroids in stress, drug craving and drug use in cocaine use disorders | NIH | National Institute on Drug Abuse | 2021 to 2023 | $547,788 | February 1, 2019 | January 31, 2025 | MILIVOJEVIC, VERICA | reporter.nih.gov |
| Unhealthy alcohol use, other drug use, and mental health disorders: comorbidity burden in people with HIV, gaps in treatment, and impact on the HIV care continuum | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $535,104 | September 25, 2019 | August 31, 2025 | LESKO, CATHERINE | reporter.nih.gov |
| Defining the role of cortical circuit dynamics in learning and addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $514,599 | March 1, 2020 | February 28, 2023 | SICILIANO, CODY | reporter.nih.gov |
| Characterization of cortical neuronal subtypes in cocaine self-administration | NIH | National Institute on Drug Abuse | 2023 | $509,066 | June 1, 2023 | May 31, 2025 | FERGUSON, SUSAN MARIE | reporter.nih.gov |
| Cocaine-motivated behaviors: development of novel viral-based strategies to target orexinergic input to the infralimbic cortex. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $501,228 | August 1, 2022 | July 31, 2025 | MARTIN-FARDON, REMI | reporter.nih.gov |
| Orexin/hypocretin as a common mediator of stress and reward behavior in cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $498,000 | March 1, 2019 | April 30, 2023 | JAMES, MORGAN H. | reporter.nih.gov |
| A novel role for the medial amygdala in the modulation of sex differences in cocaine reward | NIH | National Institute on Drug Abuse | 2021 to 2022 | $497,999 | May 1, 2018 | June 30, 2024 | WALKER, DEENA M. | reporter.nih.gov |
| Intersecting genetic risk for extreme cocaine self-administration with dopamine neurotransmission | NIH | National Institute on Drug Abuse | 2024 to 2025 | $497,999 | January 1, 2024 | December 31, 2026 | BAGLEY, JARED R | reporter.nih.gov |
| Discovery and Characterization of Genetic Mechanisms Driving Stress-induced Addiction Vulnerability | NIH | National Institute on Drug Abuse | 2021 to 2022 | $497,966 | July 1, 2020 | June 30, 2024 | DICKSON, PRICE EVANS | reporter.nih.gov |
| Information encoding by spatiotemporal patterns of dopamine release | NIH | National Institute on Drug Abuse | 2024 to 2025 | $497,791 | April 1, 2024 | March 31, 2027 | COSTA, KAUE MACHADO | reporter.nih.gov |
| Prevention of Methamphetamine Use among Postpartum Women (PROMPT) | NIH | National Institute on Drug Abuse | 2021 to 2022 | $496,125 | June 1, 2022 | May 31, 2024 | SMID, MARCELA | reporter.nih.gov |
| Molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis: Role of NLRP3 inflammasome | NIH | National Institute on Drug Abuse | 2025 | $490,172 | April 15, 2025 | January 31, 2030 | BUCH, SHILPA J | reporter.nih.gov |
| Using CRISPR tools to uncover the role of CREB-gene regulation in drug abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $490,120 | May 1, 2020 | April 30, 2023 | HAMILTON, PETER JAMES | reporter.nih.gov |
| Summer Undergraduate Research Program in Neuroscience of Addiction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $489,258 | July 1, 2012 | March 31, 2028 | LAVIN, ANTONIETA | reporter.nih.gov |
| Action of psychostimulant drugs on neuronal intrinsic excitability and drug-seeking behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $486,000 | April 1, 2018 | January 31, 2024 | KOURRICH, SAID | reporter.nih.gov |
| Dysregulation of midbrain GABAergic circuitry contributes to the motivational properties of cocaine | NIH | National Institute on Drug Abuse | 2021 to 2023 | $477,903 | June 15, 2019 | April 30, 2024 | OSTROUMOV, ALEXEY | reporter.nih.gov |
| Investigating the Impact of Nicotine and Alcohol Co-Use on the Abuse Potential of Cocaine In Monkey Models | NIH | National Institute on Drug Abuse | 2025 | $474,347 | August 15, 2025 | April 30, 2030 | NADER, MICHAEL A | reporter.nih.gov |
| Control of drug-reward behavior and relapse vulnerability via a specialized serotonergic-septohippocampal circuit | NIH | National Institute on Drug Abuse | 2024 to 2025 | $466,125 | July 15, 2024 | September 30, 2026 | DYMECKI, SUSAN M. | reporter.nih.gov |
| Targeting neural, behavioral and pharmacological mechanisms of drug memories in cocaine addiction | NIH | National Institute on Drug Abuse | 2022 to 2023 | $464,750 | September 30, 2022 | August 31, 2024 | GOLDSTEIN, RITA Z | reporter.nih.gov |
| Elucidating phenotype and etiology of substance use disorders via integrative analysis of multi-dimensional datasets | NIH | National Institute on Drug Abuse | 2023 | $462,378 | August 1, 2023 | July 31, 2026 | SUN, JIANGWEN | reporter.nih.gov |
| A 11C-UCB-J PET Study of Synaptic Density in Binge Eating Disorder (BED) | NIH | National Institute of Mental Health | 2023 to 2024 | $460,625 | May 2, 2023 | April 30, 2026 | POTENZA, MARC N | reporter.nih.gov |
| Mesolimbic Nociceptin Signaling and Cocaine Reward Suppression | NIH | National Institute on Drug Abuse | 2024 to 2025 | $460,625 | June 15, 2024 | May 31, 2026 | MELIKIAN, HALEY E | reporter.nih.gov |
| Development of NLRP3 inhibitors for HIV-associated neuroinflammation in cocaine use. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $459,995 | August 1, 2024 | July 31, 2027 | KULKARNI, AMOL ANANT | reporter.nih.gov |
| Targeting Phospholipase C and Dendritic Spines to Reduce Cocaine and Heroin Motivation | NIH | National Institute on Drug Abuse | 2021 to 2023 | $455,575 | April 1, 2019 | August 16, 2023 | ANDERSON, ETHAN MICHAEL | reporter.nih.gov |
| A Human Laboratory Study of Exenatide for Reducing the Reinforcing Effects of Cocaine | NIH | National Institute on Drug Abuse | 2023 to 2024 | $453,530 | May 15, 2023 | April 30, 2026 | VERRICO, CHRISTOPHER D | reporter.nih.gov |
| Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $449,697 | February 1, 2019 | January 31, 2024 | ANDREWS, ALLISON MICHELLE | reporter.nih.gov |
| Ultra-fast high-resolution imaging of whole mouse brain for the study of drug addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $447,931 | March 1, 2021 | February 28, 2025 | FREYBERG, ZACHARY | reporter.nih.gov |
| Chromatin regulation of BDNF in cocaine craving | NIH | National Institute on Drug Abuse | 2024 to 2025 | $443,893 | July 15, 2024 | June 30, 2026 | WEST, ANNE ELIZABETH | reporter.nih.gov |
| GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $440,000 | July 15, 2025 | June 30, 2027 | CUNNINGHAM, KATHRYN A. | reporter.nih.gov |
| Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of RATTACA Rats | NIH | National Institute on Drug Abuse | 2025 | $438,750 | July 15, 2025 | June 30, 2027 | KALLUPI, MARSIDA | reporter.nih.gov |
| Dissecting and modulating cell type and circuit-specific epigenetic mechanisms of cocaine addiction | NIH | National Institute on Drug Abuse | 2025 | $436,050 | September 30, 2025 | May 31, 2030 | VELMESHEV, DMITRY | reporter.nih.gov |
| Contribution of BLA-mPFC pathway to risky choice and compulsive cocaine seeking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $432,012 | June 1, 2019 | June 30, 2026 | YATES, JUSTIN RYAN | reporter.nih.gov |
| Neural mechanisms preventing postpartum relapse to cocaine seeking in new mothers | NIH | National Institute on Drug Abuse | 2022 to 2023 | $429,417 | May 1, 2022 | April 30, 2025 | PEREIRA ARBOLEYA, MARIANA | reporter.nih.gov |
| The glucocorticoid receptor as a mechanism of top-down control of cue-motivated behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $429,000 | March 1, 2021 | February 28, 2025 | FLAGEL, SHELLY BETH | reporter.nih.gov |
| Early cannabis use and later opioid use disorder - the role of adverse childhood experiences, genetic liability and comorbid stimulant use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $427,625 | August 1, 2024 | July 31, 2027 | AGRAWAL, ARPANA | reporter.nih.gov |
| Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse | NIH | National Institute on Drug Abuse | 2022 to 2023 | $426,250 | April 1, 2022 | March 31, 2024 | SPENCER, SADE MONIQUE | reporter.nih.gov |
| Macrocyclic Arenes as Sequestrants for Drugs of Abuse | NIH | National Institute on Drug Abuse | 2024 to 2025 | $425,976 | June 15, 2024 | May 31, 2027 | ISAACS, LYLE D | reporter.nih.gov |
| Midbrain astrocyte energy metabolism regulating drug-evoked dopamine release and behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $425,908 | May 1, 2021 | April 30, 2024 | WANAT, MATTHEW J. | reporter.nih.gov |
| Cue Incubation in Substance Use Disorders: Validation and Assessment of Mechanisms | NIH | National Institute on Drug Abuse | 2021 to 2022 | $424,875 | May 1, 2021 | April 30, 2026 | BERNAT, EDWARD M. | reporter.nih.gov |
| The Role of Endothelial Injury and Myeloid Cell Migration in the Activation of Inflammasomes in HIV infection and Cocaine Exposure | NIH | National Institute on Drug Abuse | 2024 to 2025 | $424,875 | September 30, 2024 | August 31, 2027 | NEKHAI, SERGEI | reporter.nih.gov |
| Cocaine self-administration and cholesterol metabolism | NIH | National Institute on Drug Abuse | 2022 to 2023 | $422,192 | August 1, 2022 | July 31, 2025 | CHEN, RONG | reporter.nih.gov |
| Preclinical Trial: Targeting the Neuropeptide S Receptor to Curb Opioid Taking and Seeking | NIH | National Institute on Drug Abuse | 2024 | $419,876 | September 15, 2024 | August 31, 2026 | CLARK, STEWART DONALDSON | reporter.nih.gov |
| Reward Homeostasis, Accumbens AMPA Receptor Trafficking and Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $419,513 | July 15, 2021 | June 30, 2024 | CARR, KENNETH D | reporter.nih.gov |
| Selective real-time activation of ERK1/2 signaling in dopamine neurons | NIH | National Institute on Drug Abuse | 2022 to 2023 | $416,625 | September 30, 2022 | August 31, 2025 | MORTENSEN, OLE VALENTE | reporter.nih.gov |
| HIV and estrogen effects on hypothalamic regulation of cocaine-related behavior | NIH | National Institute on Drug Abuse | 2024 to 2025 | $416,625 | August 1, 2024 | July 31, 2026 | BARKER, JACQUELINE M | reporter.nih.gov |
| Imaging neural, astrocytic and vascular synchronization to assess cocaine's effects on mPFC | NIH | National Institute on Drug Abuse | 2023 to 2024 | $416,248 | June 1, 2023 | May 31, 2025 | PAN, YINGTIAN | reporter.nih.gov |
| The role of negative reinforcement in drug abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $413,126 | March 1, 2021 | February 29, 2024 | BANKS, MATTHEW L | reporter.nih.gov |
| Discovery of genetic and genomic mechanisms driving the relationship between social reward and cocaine addiction | NIH | National Institute on Drug Abuse | 2022 to 2023 | $407,000 | August 1, 2022 | July 31, 2025 | DICKSON, PRICE EVANS | reporter.nih.gov |
| Regulation of cocaine use by astrocyte voltage-gated channels | NIH | National Institute on Drug Abuse | 2024 to 2025 | $405,746 | April 1, 2024 | March 31, 2027 | ORTINSKI, PAVEL IVANOVICH | reporter.nih.gov |
| Advancing Nr4a1 as a novel target in cocaine use disorder. | NIH | National Institute on Drug Abuse | 2025 | $405,230 | January 15, 2025 | December 31, 2026 | HELLER, ELIZABETH A | reporter.nih.gov |
| Novel cellular markers of drug-mediated calcium signaling in astrocytes | NIH | National Institute on Drug Abuse | 2021 to 2022 | $405,199 | March 15, 2021 | February 29, 2024 | REISSNER, KATHRYN JOANNA | reporter.nih.gov |
| Short-term Outcome of Stimulant Use Disorder Treatment Trials | NIH | National Institute on Drug Abuse | 2024 | $403,206 | July 1, 2024 | June 30, 2026 | MOJTABAI, RAMIN | reporter.nih.gov |
| Sex Difference in Cocaine-Induced Impulsivity: Contribution of the Mesocorticolimbic Dopamine System and Estradiol | NIH | National Institute on Drug Abuse | 2025 | $400,836 | July 15, 2025 | June 30, 2028 | PAINE, TRACIE ANN | reporter.nih.gov |
| Targeting Immunometabolism: a novel role for itaconate in the treatment of HIV-associated neurocognitive disorder and cocaine use disorder | NIH | National Institute on Drug Abuse | 2023 to 2024 | $400,798 | May 1, 2023 | April 30, 2026 | SHTUTMAN, MICHAEL | reporter.nih.gov |
| Advancing FGF13-Nav1.6 modulators to normalize Nucleus Accumbens activity for Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $400,000 | May 15, 2025 | April 30, 2027 | LIJFFIJT, MARIJN | reporter.nih.gov |
| Cell-Types Specific Neuroadaptations in the Nucleus Accumbens Shell Associated with Individual Differences in Cocaine-Seeking | NIH | National Institute on Drug Abuse | 2024 to 2025 | $393,868 | September 30, 2021 | January 31, 2027 | CARRERO, JEFFREY PARRILLA | reporter.nih.gov |
| Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing | NIH | National Institute on Drug Abuse | 2022 to 2023 | $387,500 | September 15, 2022 | August 31, 2024 | DRENAN, RYAN MICHAEL | reporter.nih.gov |
| Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing | NIH | National Institute on Drug Abuse | 2025 | $380,460 | September 15, 2022 | November 30, 2027 | DRENAN, RYAN MICHAEL | reporter.nih.gov |
| Drd3 transcript variants and cocaine self-administration | NIH | National Institute on Drug Abuse | 2024 to 2025 | $378,869 | September 1, 2024 | August 31, 2026 | CHEN, RONG | reporter.nih.gov |
| Oxytocin Induces Retrograde Metaplasticity to Attenuate CocainePreference Behavior | NIH | National Institute on Drug Abuse | 2023 to 2024 | $371,023 | September 30, 2023 | August 31, 2025 | LEONG, KAH CHUNG | reporter.nih.gov |
| Nucleus accumbens cholinergic interneurons and cue-induced cocaine craving | NIH | National Institute on Drug Abuse | 2023 to 2024 | $370,694 | July 1, 2023 | January 31, 2026 | KAWA, ALEXANDER BORG | reporter.nih.gov |
| Investigating microbiota of the gut-brain axis and the impact of cocaine | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $370,212 | September 1, 2023 | July 31, 2027 | JAVAN, GULNAZ | reporter.nih.gov |
| Using novel data sources across genetic, biological, and social domains to refine genome-wide investigations of substance use disorders | NIH | National Institute on Drug Abuse | 2024 to 2025 | $362,080 | August 1, 2024 | July 31, 2029 | DEAK, JOSEPH D. | reporter.nih.gov |
| Role of Dopamine Neuron-Specific Gene Enhancers in Cocaine Relapse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $359,310 | February 15, 2019 | July 31, 2023 | TUESTA, LUIS MIGUEL | reporter.nih.gov |
| Immune profiling of antibodies and B cells that recognize HIV and substances in people who use substances and live with HIV (PWUSH) | NIH | National Institute on Drug Abuse | 2025 | $356,630 | September 1, 2025 | August 31, 2027 | WU, XUELING | reporter.nih.gov |
| Determining how neurotensin mediates valence processing and compulsive cocaine seeking | NIH | National Institute on Drug Abuse | 2022 to 2023 | $345,168 | February 1, 2022 | January 31, 2024 | LI, HAO | reporter.nih.gov |
| Advancing mGlu1 positive allosteric modulators as therapeutics to facilitate abstinence in cocaine use disorder | NIH | National Institute on Drug Abuse | 2022 | $325,386 | September 30, 2022 | September 29, 2025 | WOLF, MARINA ELIZABETH | reporter.nih.gov |
| Investigation of a Novel PDE4B Inhibitor for Stimulant Use Disorder | NIH | National Institute on Drug Abuse | 2024 | $320,000 | May 1, 2024 | April 30, 2026 | VARADHACHARY, ATUL | reporter.nih.gov |
| Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase | NIH | National Institute on Drug Abuse | 2023 | $319,547 | September 15, 2023 | September 14, 2025 | XIE, XINMIN SIMON | reporter.nih.gov |
| AI-assisted behavioral profiling of an invertebrate model to identify new psychedelic therapeutics for stimulant use disorders | NIH | National Institute on Drug Abuse | 2022 | $318,373 | April 1, 2022 | September 30, 2023 | PATEL, DHAVAL SUBHAS | reporter.nih.gov |
| Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | NIH | National Institute on Drug Abuse | 2022 | $312,310 | April 1, 2022 | September 30, 2023 | VARSHNEY, JYOTIKA | reporter.nih.gov |
| HIV effects on astrocytic regulation of stress-induced cocaine reinstatement | NIH | National Institute on Drug Abuse | 2024 to 2025 | $303,000 | June 15, 2024 | May 31, 2026 | GIACOMETTI, LAURA L | reporter.nih.gov |
| Investigate B cell perturbations and immune reconstitution failure in response to antiretroviral therapy in HIV-infected cocaine users | NIH | National Institute on Drug Abuse | 2022 to 2023 | $302,000 | August 15, 2022 | July 31, 2025 | JIANG, WEI | reporter.nih.gov |
| Developing a novel epigenetic regulator as a treatment for cocaine use disorder | NIH | National Institute on Drug Abuse | 2024 | $295,325 | June 1, 2024 | May 31, 2025 | KIM, THOMAS | reporter.nih.gov |
| Mechanisms of mGlu1 regulation of cortical inhibition and cognitive function: Implications in adolescent cocaine exposure | NIH | National Institute on Drug Abuse | 2024 to 2025 | $288,470 | April 1, 2024 | March 31, 2026 | LUESSEN, DEBORAH JOYCE | reporter.nih.gov |
| Decoding the dynamic representation of reward predictions across mesocorticostriatal circuits during learning | NIH | National Institute on Drug Abuse | 2022 | $283,500 | May 1, 2020 | April 30, 2025 | NIV, YAEL | reporter.nih.gov |
| Ventral Pallidum Circuits in Motivation, Risky Decision Making, and Opioid Addiction | NIH | National Institute on Drug Abuse | 2022 to 2024 | $274,286 | September 30, 2020 | August 31, 2025 | FARRELL, MITCHELL | reporter.nih.gov |
| Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disorders | NIH | National Institute on Drug Abuse | 2022 to 2023 | $273,684 | February 15, 2022 | January 31, 2025 | DEPOY, LAUREN MARIE | reporter.nih.gov |
| Neural activity-based candidate gene identification to link eating disorders and drug addiction | NIH | National Institute on Drug Abuse | 2023 | $271,500 | July 1, 2023 | June 30, 2024 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Mentalizing deficits in cocaine addiction, associations with immune dysregulation and childhood maltreatment | NIH | National Institute on Drug Abuse | 2021 to 2022 | $260,140 | March 15, 2018 | February 28, 2023 | BACHI, KEREN | reporter.nih.gov |
| Investigation of how sex steroids and nicotinic acetylcholine receptors promote cocaine self-administration | NIH | National Institute on Drug Abuse | 2023 to 2025 | $252,158 | December 1, 2020 | January 31, 2027 | SNEDDON, ELIZABETH | reporter.nih.gov |
| Orexin/hypocretin as a common mediator of stress and reward behavior in cocaine addiction | NIH | National Institute on Drug Abuse | 2023 | $249,000 | March 1, 2019 | April 30, 2025 | JAMES, MORGAN H. | reporter.nih.gov |
| Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disorders | NIH | National Institute on Drug Abuse | 2025 | $248,996 | February 15, 2022 | January 31, 2028 | DEPOY, LAUREN MARIE | reporter.nih.gov |
| Engineering chemoproteomic tools for identifying molecular mechanisms of substance use disorders | NIH | National Institute on Drug Abuse | 2025 | $246,000 | March 15, 2024 | February 28, 2027 | KIM, CHRISTINA | reporter.nih.gov |
| Rapid protein translation in nucleus accumbens neurons in response to a cocaine-associated cue | NIH | National Institute on Drug Abuse | 2025 | $234,000 | April 15, 2025 | March 31, 2027 | WOLF, MARINA ELIZABETH | reporter.nih.gov |
| Contributions of KCNQ2/3 channels to medium spiny neuron excitability and cocaine reward | NIH | National Institute on Drug Abuse | 2023 to 2025 | $225,897 | May 1, 2023 | April 30, 2026 | JORGENSEN, EMILY | reporter.nih.gov |
| Validation of a rat model of co-morbid cocaine and alcohol use | NIH | National Institute on Drug Abuse | 2025 | $225,000 | September 1, 2025 | July 31, 2027 | GILPIN, NICHOLAS WARREN | reporter.nih.gov |
| Integrating preclinical models to develop converging mechanistic data in co-occuring HIV and substance use | NIH | National Institute on Drug Abuse | 2022 | $222,260 | July 1, 2020 | June 30, 2024 | BARKER, JACQUELINE M | reporter.nih.gov |
| Affective States and Large-scale Network Activity | NIH | National Institute on Drug Abuse | 2025 | $206,955 | June 15, 2025 | May 31, 2027 | DOUTON, JOAQUIN E | reporter.nih.gov |
| Single Cell Encoding of Cocaine Seeking Behavior in the Nucleus Accumbens | NIH | National Institute on Drug Abuse | 2021 to 2024 | $202,476 | July 1, 2020 | April 30, 2025 | CHALHOUB, REDA | reporter.nih.gov |
| Neural activity-based candidate gene identification to link eating disorders and drug addiction | NIH | National Institute on Drug Abuse | 2024 | $201,750 | July 1, 2024 | June 30, 2025 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Engineering chemoproteomic tools for identifying molecular mechanisms of substance use disorders | NIH | National Institute on Drug Abuse | 2024 | $189,579 | March 15, 2024 | January 15, 2025 | KIM, CHRISTINA | reporter.nih.gov |
| Role of parasubthalamic astrocytic dysfunction in alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $181,753 | February 1, 2023 | January 31, 2028 | WHITE, ALLISON | reporter.nih.gov |
| Investigation of the Molecular Mechanisms Underlying Astrocytic CREB's Regulation of Cocaine Drug-Seeking | NIH | National Institute on Drug Abuse | 2025 | $180,646 | December 15, 2024 | November 30, 2029 | HOLT, LEANNE | reporter.nih.gov |
| From synapse to function: cocaine-induced cell-type- and circuit-specific accumbal proteome changes | NIH | National Institute on Drug Abuse | 2025 | $180,606 | April 1, 2025 | March 31, 2030 | YIM, YUN YOUNG | reporter.nih.gov |
| Accumbal integration of brain wide glutamatergic inputs and their dysregulation by cocaine self-administration | NIH | National Institute on Drug Abuse | 2022 to 2025 | $175,861 | June 1, 2022 | May 31, 2026 | GABRIEL, STEPHANIE ANN CAJIGAS | reporter.nih.gov |
| Corticolimbic circuit and neuroimmune mechanisms of comorbid HIV and cocaine use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $161,324 | July 1, 2024 | June 30, 2026 | NAMBA, MARK D | reporter.nih.gov |
| Repurposing Metformin as a Treatment for Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $159,738 | September 27, 2023 | September 26, 2027 | HERNANDEZ, EDITH | reporter.nih.gov |
| Age and sex-differences in reward responding after punishment | NIH | National Institute on Drug Abuse | 2025 | $159,625 | July 1, 2025 | June 30, 2027 | MARINELLI, MICHELA (MICKY) | reporter.nih.gov |
| Rhythms in Cholinergic Interneuron Activity Mediate Drug-Taking Behaviors | NIH | National Institute on Drug Abuse | 2024 to 2025 | $152,324 | September 1, 2024 | August 31, 2026 | STOWE, TAYLOR ASHLEY | reporter.nih.gov |
| Estrogen receptor regulation of cocaine effects on dopamine terminals | NIH | National Institute on Drug Abuse | 2022 to 2025 | $149,266 | September 1, 2022 | June 30, 2026 | ERICKSON, KIRSTY R. | reporter.nih.gov |
| Enabling Discovery-Based Brain Metabolomics with Ultra-High Resolution Liquid Chromatography and Machine Learning | NIH | National Institute on Drug Abuse | 2024 to 2025 | $148,460 | July 1, 2024 | June 30, 2027 | CAIN, CAITLIN | reporter.nih.gov |
| Cocaine effects on spatial patterns of striatal dopamine release | NIH | National Institute on Drug Abuse | 2024 to 2025 | $148,112 | June 1, 2024 | May 31, 2027 | REILEY, HANNAH | reporter.nih.gov |
| Astrocyte-mediated regulation of cocaine-generated synapses during cocaine seeking | NIH | National Institute on Drug Abuse | 2023 to 2025 | $146,206 | September 1, 2023 | August 31, 2026 | ZINSMAIER, ALEXANDER | reporter.nih.gov |
| 5-HT7 receptor modulation of cocaine effects | NIH | National Institute on Drug Abuse | 2022 to 2023 | $144,503 | August 1, 2022 | July 31, 2025 | OLIVE, M. FOSTER | reporter.nih.gov |
| Relapse to drug-seeking behavior is regulated by medial habenula NR4A2 in male and female mice | NIH | National Institute on Drug Abuse | 2022 to 2023 | $143,574 | March 1, 2022 | February 29, 2024 | CHILDS, JESSICA ERIN | reporter.nih.gov |
| Synaptogyrin-3 promotes behavioral resilience and protects against cocaine-induced dopaminergic adaptations | NIH | National Institute on Drug Abuse | 2021 to 2023 | $140,482 | February 16, 2021 | April 30, 2025 | PECK, EMILY GRACE | reporter.nih.gov |
| Investigating the ventral pallidum-ventral tegmental area circuit in cocaine relapse | NIH | National Institute on Drug Abuse | 2022 to 2024 | $140,303 | March 8, 2022 | March 22, 2024 | CAMPBELL, RIANNE | reporter.nih.gov |
| Intersecting genetic risk for extreme cocaine self-administration with dopamine neurotransmission | NIH | National Institute on Drug Abuse | 2023 | $140,144 | January 1, 2023 | December 31, 2023 | BAGLEY, JARED R | reporter.nih.gov |
| Circuit mechanisms underlying inflexible habitual behaviors following chronic cocaine use | NIH | National Institute on Drug Abuse | 2025 | $136,929 | April 1, 2025 | March 31, 2027 | CHEVEE, MAXIME F. | reporter.nih.gov |
| Defining sex differences in GABA regulation of dopamine release in cocaine use disorder | NIH | National Institute on Drug Abuse | 2022 to 2025 | $134,187 | September 1, 2022 | August 31, 2026 | CHRISTENSEN, BROOKE A. | reporter.nih.gov |
| Developing an Ex Vivo Model of the Mesolimbic Pathway for Studying Addiction Phenotypes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $126,352 | April 15, 2021 | April 14, 2024 | RUDIBAUGH, THOMAS | reporter.nih.gov |
| Resting State fMRI Functional and Effective Connectivity in Opioid and Cocaine Use Disorders | NIH | National Institute on Drug Abuse | 2022 to 2024 | $123,065 | June 10, 2022 | June 9, 2025 | WOISARD, KYLE | reporter.nih.gov |
| FGF13 Control of Hippocampal Excitability in Cocaine Contextual Memory | NIH | National Institute on Drug Abuse | 2022 to 2024 | $122,013 | April 1, 2022 | July 28, 2024 | LIN, SUSAN | reporter.nih.gov |
| Cocaine-Mediated Modulation of Dopamine Transmission and Its Effects on Peripheral Immunity | NIH | National Institute on Drug Abuse | 2025 | $118,962 | July 1, 2025 | June 30, 2027 | GOPINATH, ADITHYA K | reporter.nih.gov |
| Kappa Opioid Receptor Availability, Social Rank, and Cocaine Self-Administration in Female and Male Monkeys | NIH | National Institute on Drug Abuse | 2022 to 2024 | $117,170 | February 1, 2022 | March 29, 2024 | JOHNSON, BERNARD N | reporter.nih.gov |
| Reversing Cocaine-induced Neurobehavioral Deficits using a Combination Drug Approach | NIH | National Institute on Drug Abuse | 2021 to 2023 | $116,987 | January 15, 2019 | March 14, 2023 | ESTAVE, PAIGE MARIE | reporter.nih.gov |
| The influence of peroxisome proliferator-activated receptor gamma coactivator - 1 alpha (PGC-1a) on the nucleus accumbens during cocaine-self-administration | NIH | National Institute on Drug Abuse | 2021 to 2022 | $114,062 | September 2, 2021 | May 1, 2023 | CALARCO, CALI ANN | reporter.nih.gov |
| Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $111,489 | August 1, 2023 | July 31, 2027 | EMERSON, SOREN D | reporter.nih.gov |
| Concurrent chronic stress and cocaine self-administration: Understanding effects on mPFC microglia and drug choice behavior | NIH | National Institute on Drug Abuse | 2024 to 2025 | $108,512 | July 1, 2024 | April 30, 2028 | NOWAK, DAVID B | reporter.nih.gov |
| FMRP in the striatum: mechanisms of early drug reward | NIH | National Institute on Drug Abuse | 2021 to 2022 | $105,669 | April 1, 2021 | March 31, 2023 | HUEBSCHMAN, JESSICA | reporter.nih.gov |
| Involvement of Gq Signaling in the Mobilization of 2-Arachidonoylglycerol by Corticosterone in the Prefrontal Cortex | NIH | National Institute on Drug Abuse | 2024 to 2025 | $98,512 | April 1, 2024 | March 31, 2027 | LASKOWSKI, LAUREN J | reporter.nih.gov |
| Opioidergic mechanisms underlying cocaine conditioned reinforcement | NIH | National Institute on Drug Abuse | 2021 to 2023 | $97,312 | August 1, 2021 | December 10, 2023 | RYSZTAK, LAUREN GRACE | reporter.nih.gov |
| Systems Genetics of Cocaine Preference in Drosophila | NIH | National Institute on Drug Abuse | 2023 to 2024 | $96,668 | September 8, 2023 | September 7, 2025 | HATFIELD, JEFFREY S | reporter.nih.gov |
| Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake | NIH | National Institute on Drug Abuse | 2023 to 2024 | $96,668 | March 15, 2023 | March 14, 2025 | IACINO, MELODY COURTNEY-LYNN | reporter.nih.gov |
| Characterizing BLA dopaminergic and glutamatergic mechanisms of dynamic drug seeking | NIH | National Institute on Drug Abuse | 2024 to 2025 | $95,260 | February 12, 2024 | February 11, 2027 | BRICKNER, MEGAN A | reporter.nih.gov |
| Extended amygdala mGlu8 receptor signaling in stress-reward interactions | NIH | National Institute on Drug Abuse | 2021 to 2023 | $94,759 | July 1, 2021 | June 30, 2024 | NABIT, BRETTON | reporter.nih.gov |
| Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition Rates | NIH | National Institute on Drug Abuse | 2022 to 2023 | $94,446 | January 2, 2022 | January 1, 2024 | LEACH, AMY CLAIRE | reporter.nih.gov |
| Identifying the Distinct Intracellular Pathways That Mediate Dopamine-Driven Behaviors | NIH | National Institute on Drug Abuse | 2021 to 2022 | $92,788 | September 1, 2021 | August 31, 2023 | RAUFFENBART, CAROLINE | reporter.nih.gov |
| Recruitment of striatal enkephalin by cocaine as a substrate for striatopallidal circuit adaptations and cocaine seeking | NIH | National Institute on Drug Abuse | 2024 to 2025 | $92,106 | June 1, 2024 | May 31, 2027 | MATSUMURA, KANAKO | reporter.nih.gov |
| Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior | NIH | National Institute on Drug Abuse | 2023 to 2024 | $91,456 | August 9, 2023 | August 8, 2026 | GAULDEN, ANDREW | reporter.nih.gov |
| Role of Reelin protein in the cellular and behavioral response to drugs of abuse | NIH | National Institute on Drug Abuse | 2024 to 2025 | $90,850 | April 1, 2024 | March 31, 2027 | BRIDA, KASEY LYNN | reporter.nih.gov |
| Investigating the role of locus coeruleus in conditioned cocaine-stimulus control of attention | NIH | National Institute on Drug Abuse | 2021 to 2022 | $90,721 | July 1, 2019 | June 30, 2023 | PRESKER, MARK ANTON | reporter.nih.gov |
| The effect of ethanol self-administration on cocaine reinforcement in male and female monkeys | NIH | National Institute on Drug Abuse | 2024 to 2025 | $86,188 | April 1, 2024 | November 29, 2025 | ROUGH, MIA ISABEL | reporter.nih.gov |
| The design, synthesis, and evaluation of natural product-inspired small molecules targeting the 5-HT2C receptor as novel therapeutics for opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2022 | $83,776 | April 1, 2020 | March 31, 2023 | ORR, MEGHAN JO | reporter.nih.gov |
| Defining the role of glucocorticoid-related dendritic spine plasticity in cocaine-induced habits | NIH | National Institute on Drug Abuse | 2021 to 2022 | $80,919 | June 9, 2020 | December 31, 2022 | SEQUEIRA, MICHELLE KATHRYN | reporter.nih.gov |
| Mechanisms of nicotinic acetylcholine receptor modulation of cocaine reward | NIH | National Institute on Drug Abuse | 2022 to 2023 | $80,437 | July 1, 2022 | August 15, 2023 | MOEN, JANNA K | reporter.nih.gov |
| Dopaminergic regulation of aversion-motivated behaviors | NIH | National Institute on Drug Abuse | 2023 to 2025 | $78,699 | August 28, 2023 | January 9, 2026 | GRAFELMAN, ELAINE | reporter.nih.gov |
| Impact of cocaine-associated cues and contexts on adolescent relapse | NIH | National Institute on Drug Abuse | 2025 | $78,500 | May 1, 2025 | April 30, 2027 | JOHNSON, ALEXANDER W. | reporter.nih.gov |
| Investigating cytoskeletal dynamics in astrocyte structure and cocaine seeking behavior | NIH | National Institute on Drug Abuse | 2022 to 2023 | $78,176 | September 1, 2022 | August 31, 2024 | FRANKLIN, JANAY | reporter.nih.gov |
| Specificity and stability of cocaine ensembles | NIH | National Institute on Drug Abuse | 2025 | $77,612 | June 24, 2025 | June 23, 2027 | BARTH, BRADLEY BRIGHAM | reporter.nih.gov |
| Exploring striatal circuits underlying behavioral flexibility during punishment of cocaine seeking | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $77,523 | September 15, 2022 | September 14, 2024 | CRUZ, ADELIS MARIE | reporter.nih.gov |
| Defining Disruptions to Dopaminergic Control of Striatal Activity after Chronic Cocaine Use | NIH | National Institute on Drug Abuse | 2024 | $77,284 | July 1, 2024 | June 30, 2025 | LEONARD, MICHAEL Z. | reporter.nih.gov |
| Interaction of HIV-1 Nef and glutamate homeostasis in the nucleus accumbens during cocaine addiction | NIH | National Institute on Drug Abuse | 2022 to 2023 | $76,160 | September 1, 2022 | August 31, 2024 | PLA TENORIO, JESSALYN GABRIELLE | reporter.nih.gov |
| The role of nucleus accumbens dopamine in incubation of cocaine craving | NIH | National Institute on Drug Abuse | 2023 to 2024 | $74,771 | March 8, 2023 | June 28, 2024 | WEBER, SOPHIA JIAHN | reporter.nih.gov |
| Dissecting the role of amygdalo-striatal circuits in the regulation of stress and cocaine comorbidity in rats | NIH | National Institute on Drug Abuse | 2021 to 2022 | $73,256 | July 1, 2021 | June 30, 2023 | MORALES-SILVA, ROBERTO J | reporter.nih.gov |
| Cell Subtype Transcriptional Role of Nab2 in Cocaine Self Administration | NIH | National Institute on Drug Abuse | 2021 to 2022 | $69,756 | August 30, 2021 | May 17, 2023 | CHOI, ERIC Y | reporter.nih.gov |
| The Role of Estradiol on Central Dopamine Signaling and its Associations with Cocaine Preference and Exercise | NIH | National Institute on Drug Abuse | 2022 to 2023 | $68,340 | August 5, 2022 | August 4, 2024 | SHAY, DUSTI | reporter.nih.gov |
| Designing synthetic transcription factors to study drug-specific transcription and behaviors | NIH | National Institute on Drug Abuse | 2023 to 2024 | $66,095 | June 25, 2023 | November 29, 2024 | PICONE, JOSEPH ANTHONY | reporter.nih.gov |
| Competing basolateral amygdala inputs to the infralimbic and prelimbic cortices in cocaine-seeking behavior | NIH | National Institute on Drug Abuse | 2024 to 2025 | $64,595 | February 8, 2024 | November 2, 2025 | ZIMBELMAN, ALEXA RYAN | reporter.nih.gov |
| Defining the neural ensembles of cocaine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $62,224 | June 1, 2020 | May 31, 2023 | THIBEAULT, KIMBERLY C | reporter.nih.gov |
| Claustrum serotonin and spike-timing plasticity associated with cognitive deficits after cocaine | NIH | National Institute on Drug Abuse | 2023 to 2025 | $58,453 | November 1, 2023 | March 31, 2025 | ANDERSON, TANNER | reporter.nih.gov |
| Polysubstance use and mental health outcomes after substance abuse treatment among community-based men of color who have sex with men in Los Angeles living with and without HIV | NIH | National Institute on Drug Abuse | 2023 | $52,499 | September 30, 2023 | August 31, 2024 | KOERBER, JULIA JAN | reporter.nih.gov |
| The effect of opioids, stimulants, and the simultaneous use of both on the hepatitis C virus (HCV) cascade of care in rural communities in the United States | NIH | National Institute on Drug Abuse | 2022 to 2023 | $51,995 | May 3, 2022 | May 7, 2023 | ESTADT, ANGELA T | reporter.nih.gov |
| Mechanisms of Nucleus Accumbens Cell-Type Specific Deep Brain Stimulation in Cocaine Reinstatement | NIH | National Institute on Drug Abuse | 2023 | $49,182 | January 8, 2022 | September 7, 2023 | RICH, MATTHEW T | reporter.nih.gov |
| Investigation of Novel Drug Targets for Stimulant Use Disorder | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $48,694 | February 1, 2023 | December 8, 2023 | WHITE, ALLISON | reporter.nih.gov |
| Elucidating the Mechanisms and Relevance of Cocaine-Induced Plasticity of Inhibitory G Protein Signaling in the Prelimbic Cortex | NIH | National Institute on Drug Abuse | 2025 | $47,042 | June 1, 2025 | May 31, 2028 | WELTER, ALEX LARSEN | reporter.nih.gov |
| Epigenetic Mechanisms Underlying Drug-seeking Behavior: Role of HDAC3 in Regulating Gene Expression within the MHb Cholinergic Population for Cocaine-induced Relapse-like Behavior | NIH | National Institute on Drug Abuse | 2024 | $44,850 | April 1, 2024 | March 31, 2025 | ALIZO VERA, VANESSA | reporter.nih.gov |
| The role of NPAS4 in drug addiction | NIH | National Institute on Drug Abuse | 2022 | $44,208 | July 1, 2021 | June 30, 2022 | HUGHES, BRANDON W. | reporter.nih.gov |
| The role of dopamine in OFC-DMS plasticity in punishment-resistant reward-seeking behavior | NIH | National Institute on Drug Abuse | 2024 | $44,187 | June 1, 2024 | May 31, 2025 | MWENDA, NKATHA KARIMI | reporter.nih.gov |
| Muscarinic Receptor Mediation of Cocaine-Dependent Reward Signals: Impact of Pharmacological Modulation | NIH | National Institute on Drug Abuse | 2025 | $44,160 | August 25, 2025 | August 24, 2028 | GEISLER, ELIZABETH STELLA | reporter.nih.gov |
| Molecular and Functional Characterization of Transcriptionally Defined Subpopulations of VTA Dopamine Neurons | NIH | National Institute on Drug Abuse | 2025 | $43,420 | May 1, 2025 | October 31, 2027 | FITZGERALD, NATALIE DALTON | reporter.nih.gov |
| Role of PL CaMKII in incubated cocaine-craving | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $43,017 | September 13, 2024 | August 31, 2025 | HUERTA SANCHEZ, LAURA | reporter.nih.gov |
| DREADD Manipulations of Drug Choice | NIH | National Institute on Drug Abuse | 2023 | $41,535 | July 1, 2023 | May 24, 2024 | ROBINSON, HANNAH | reporter.nih.gov |
| Structural and functional responses of nucleus accumbens microglia following long-access cocaine self-administration | NIH | National Institute on Drug Abuse | 2024 | $40,441 | August 1, 2024 | July 31, 2025 | BELLINGER, TANIA JAZMINE | reporter.nih.gov |
| Norepinephrine modulates medial prefrontal cortex neural ensembles that control cocaine seeking behavior | NIH | National Institute on Drug Abuse | 2022 | $40,364 | June 15, 2022 | September 30, 2022 | GHEIDI, ALI | reporter.nih.gov |
| Influence of fear conditioning prior to cocaine self-administration on cocaine seeking in adult rats: assessing the role of the frontostriatal circuits in trauma and cocaine use co-occurrence | NIH | National Institute on Drug Abuse | 2024 | $39,552 | July 1, 2024 | June 30, 2025 | PEREZ, YOBET A | reporter.nih.gov |
| The Role of Prelimbic Corticotrophin Releasing Factor Type 1 Receptor and L-Type Calcium Channels in Stress-induced Relapse | NIH | National Institute on Drug Abuse | 2025 | $37,522 | April 1, 2025 | June 30, 2028 | UCHENDU, STACY NDIDI | reporter.nih.gov |
| Defining the effects of cocaine delivery speed on the encoding of drug-cue associations | NIH | National Institute on Drug Abuse | 2025 | $34,980 | September 1, 2025 | August 31, 2030 | CLARITY, THOMAS | reporter.nih.gov |
| Investigating the Role of Gilz, an X-linked Gene, in Regulating Cocaine-Induced Cellular Activity and Cocaine-Associated Memory | NIH | National Institute on Drug Abuse | 2024 | $26,034 | April 1, 2024 | July 31, 2024 | ROUNDS, JACOB | reporter.nih.gov |
| Impact of Cocaine History on Pharmacotherapy Effectiveness | NIH | National Institute on Drug Abuse | 2023 | $19,379 | August 25, 2023 | January 1, 2024 | MARCUS, MADISON M | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Ut Southwestern Medical Center | Dallas, TX | 2 | $44 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 3 | $28.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 8 | $22 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 14 | $21.8 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 10 | $16 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 9 | $15.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 12 | $14.8 million | 0 | $0 |
| Allen Institute | Seattle, WA | 1 | $14.5 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 15 | $14.2 million | 0 | $0 |
| Yale University | New Haven, CT | 11 | $13.9 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 7 | $13.2 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 7 | $12.8 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 9 | $12.6 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 1 | $12.6 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 16 | $11.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 13 | $11 million | 0 | $0 |
| Phoenix Pharmalabs, Inc. | Woodscross, UT | 1 | $8.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 6 | $7.9 million | 0 | $0 |
| Florida International University | Miami, FL | 1 | $7.4 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 7 | $7.2 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 3 | $7.1 million | 0 | $0 |
| Sparian Biosciences, Inc. | New York City, NY | 1 | $6.9 million | 0 | $0 |
| Omeros Corporation | Seattle, WA | 1 | $6.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 7 | $6.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 7 | $6.3 million | 0 | $0 |
| University of Florida | Gainesville, FL | 7 | $6.2 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 4 | $6.2 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 3 | $6.1 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 9 | $5.9 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 15 | $5.6 million | 0 | $0 |
| Tempero Bio, Inc. | Oakland, CA | 1 | $5.3 million | 0 | $0 |
| Tonix Pharmaceuticals, Inc. | Chatham, NJ | 1 | $5.2 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 6 | $5.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 3 | $4.9 million | 0 | $0 |
| University of Washington | Seattle, WA | 3 | $4.6 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 4 | $4.2 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $4.1 million | 0 | $0 |
| Emory University | Atlanta, GA | 2 | $4.1 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 4 | $4 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 4 | $4 million | 0 | $0 |
| Friends Research Institute, Inc. | Baltimore, MD | 2 | $3.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 5 | $3.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 1 | $3.7 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 1 | $3.7 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 3 | $3.6 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 2 | $3.5 million | 0 | $0 |
| Southern Research Institute | Birmingham, AL | 1 | $3.4 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 2 | $3.2 million | 0 | $0 |
| University of Maryland, College Park | College Park, MD | 4 | $3.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 3 | $3.1 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 1 | $3.1 million | 0 | $0 |
| Meharry Medical College | Nashville, TN | 1 | $3 million | 0 | $0 |
| Evon Medics, LLC | Elkridge, MD | 1 | $2.9 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 2 | $2.9 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 4 | $2.9 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 3 | $2.8 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 1 | $2.8 million | 0 | $0 |
| Praeventix, LLC | Exton, PA | 1 | $2.8 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 1 | $2.8 million | 0 | $0 |
| Rbhs-Robert Wood Johnson Medical School | Piscataway, NJ | 4 | $2.6 million | 0 | $0 |
| Clemson University | Clemson, SC | 2 | $2.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 2 | $2.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 1 | $2.4 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 3 | $2.4 million | 0 | $0 |
| Duke University | Durham, NC | 4 | $2.4 million | 0 | $0 |
| University of Texas at El Paso | El Paso, TX | 3 | $2.4 million | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 1 | $2.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 2 | $2.3 million | 0 | $0 |
| Marshall University Research Corporation | Huntington, WV | 3 | $2.2 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 6 | $2.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 2 | $2.2 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 3 | $2.2 million | 0 | $0 |
| Legacy Emanuel Hospital and Health Center | Portland, OR | 1 | $2.2 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 2 | $2.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 4 | $2 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 2 | $2 million | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 2 | $2 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 1 | $2 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 1 | $1.9 million | 0 | $0 |
| University of California-Santa Barbara | Santa Barbara, CA | 2 | $1.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 5 | $1.8 million | 0 | $0 |
| Marquette University | Milwaukee, WI | 2 | $1.8 million | 0 | $0 |
| Old Dominion University | Norfolk, VA | 3 | $1.8 million | 0 | $0 |
| Washington State University | Pullman, WA | 1 | $1.7 million | 0 | $0 |
| Fordham University | Bronx, NY | 1 | $1.6 million | 0 | $0 |
| University of Texas at Dallas | Richardson, TX | 1 | $1.6 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 1 | $1.5 million | 0 | $0 |
| Eastern Virginia Medical School | Norfolk, VA | 1 | $1.5 million | 0 | $0 |
| Rowan University School/osteopathic Med | Stratford, NJ | 2 | $1.4 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 1 | $1.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 1 | $1.4 million | 0 | $0 |
| Davidson College | Davidson, NC | 2 | $1.3 million | 0 | $0 |
| Northeastern University | Boston, MA | 1 | $1.3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 1 | $1.3 million | 0 | $0 |
| American University | Washington, DC | 1 | $1.3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 2 | $1.2 million | 0 | $0 |
| Texas A&M University | College Station, TX | 2 | $1.2 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 2 | $1.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 1 | $1 million | 0 | $0 |
| Rosalind Franklin Univ of Medicine & Sci | North Chicago, IL | 1 | $1 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 195 | $124,788,697 | 0 | $0 |
| 2024 | 217 | $121,331,737 | 0 | $0 |
| 2023 | 227 | $127,939,083 | 0 | $0 |
| 2022 | 242 | $125,084,896 | 0 | $0 |
| 2021 | 158 | $82,608,736 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.